IndraLab

Statements


MYSM1 inhibits defects. 1 / 1
| 1

eidos
"Several studies have found that MYSM1 deficiency or mutation can lead to defects during the development and function of HSCs , B cells , natural killer ( NK ) cells and dendritic cells , and it also results in the development of lymphopenia , anemia , and thrombocytopenia , and low B-cell and NK-cell counts in both mice and humans [ 45,51,52,53,54,55 ] ."